Cover Image

Global, Regional, and National Prevalence of Chronic Type 2 Diabetic Kidney Disease From 1990 to 2021: A Trend and Health Inequality Analyses Based on the Global Burden of Disease Study 2021

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yujun He, Xiaoyi Wang, Lu Li, Minhui Liu, Yachao Wu, Ru Chen, Jiujie He, Wei Mai, Xiaojun Li
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Journal of Diabetes
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Global Mortality and Disability‐Adjusted Life Years Attributable to Tobacco Exposure Among Middle‐Aged and Older Adults With Type 2 Diabetes, 1990–2021: A Systematic Analysis of GBD 2021 Data With Projections to 2042
by: Yujun He, et al.
Published: (2026)

Global, Regional, and National Prevalence for Type 2 Diabetes Among Women of Childbearing Age, 1992–2021: An Age–Period–Cohort Analysis Based on the Global Burden of Disease Study 2021
by: Zhongyan Xu, et al.
Published: (2026)

Disease Burden of Type 2 Diabetes Among Young Adults in Asia: An Analysis From the Global Burden of Disease Study 2021
by: Ruoting Wang, et al.
Published: (2025)

Global, regional and national burden of blindness and vision loss attributable to diabetic retinopathy, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021
by: Yujie Pan, et al.
Published: (2025)

National burden and risk factors of diabetes mellitus in China from 1990 to 2021: Results from the Global Burden of Disease study 2021
by: Wenzhen Deng, et al.
Published: (2024)

Chronic Kidney Disease in China: Addressing the Burden With Innovative Strategies and Global Insights
by: Xiaoqiang Ding
Published: (2025)

Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021
by: Jun‐Qiao An, et al.
Published: (2025)

Worldwide burden of metabolic risk‐related cardiovascular disease from 1990 to 2021, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021
by: Xinjiang Dong, et al.
Published: (2025)

Impact of Adverse Metabolic Factors on the Burden of Chronic Kidney Disease in the Chinese Population ≥ 20 Years Old, 1990–2019
by: Jiali Huang, et al.
Published: (2026)

Temporal Trends in the Burden of Diabetes and Its Risk Factors Across the Western Pacific Region Between 1990 and 2044: A Systematic Analysis of the Global Burden of Disease Study 2019
by: Xinwei Liu, et al.
Published: (2025)

Disparities in diabetes burden in China and globally, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021
by: Min Yin, et al.
Published: (2025)

Epidemiological Transition and Forecasting of Diabetes Burden in Saudi Arabia: A Comprehensive Analysis From the Global Burden of Disease Study 1990–2023
by: Ramy Mohamed Ghazy, et al.
Published: (2026)

Socioeconomic and mental health inequalities in global burden of type 2 diabetes: Evidence from the Global Burden of Disease Study 2021
by: Mingling Chen, et al.
Published: (2025)

Diabetic Kidney Disease Update
by: Christian Mende, et al.
Published: (2025)

The Burden of Diabetes in the Southeastern Coastal Region of China From 1990 to 2019 and Projections for 2030: A Systematic Analysis of the 2019 Global Burden of Disease Study
by: Yating Ding, et al.
Published: (2025)

Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses
by: David Z. I. Cherney, et al.
Published: (2026)

Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis
by: João Sérgio Neves, et al.
Published: (2026)

Iron‐Deficiency Anemia Elevates Risk of Diabetic Kidney Disease in Type 2 Diabetes Mellitus
by: Bin Huang, et al.
Published: (2025)

Patients With Type 2 Diabetes Are at Greater Risk of Developing New Hypertension and Chronic Kidney Disease Following COVID‐19
by: Justin Y. Lu, et al.
Published: (2025)

Correction to “Iron‐Deficiency Anemia Elevates Risk of Diabetic Kidney Disease in Type 2 Diabetes Mellitus”
Published: (2025)

Trends, Social Determinants, and Lifestyle Factors Associated With Comorbidity of Diabetes and Kidney Diseases Among Chinese Adults Aged ≥ 45 Years
by: Guanghui Cui, et al.
Published: (2025)

Safety and Efficacy of Semaglutide in Patients With Chronic Kidney Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta‐Analysis
by: Ali Abdullah, et al.
Published: (2025)

Burden of type 2 diabetes in Asia‐Pacific regions, 1990–2021: GBD 2021 analysis with forecast to 2050
by: Weimin Zhu, et al.
Published: (2026)

Commentary on “Association of Serum Total Bilirubin to Cholesterol Ratio With Progression of Chronic Kidney Disease in Patients With Type 2 Diabetes: A Retrospective Cohort Study”
by: Tinghua Zhang
Published: (2025)

Inflammation in Diabetic Kidney Disease Is Linked to Gut Dysbiosis and Metabolite Imbalance
by: Xueting Zheng, et al.
Published: (2025)

Longitudinal Trajectories of Albuminuria and eGFR in Type 2 Diabetes Mellitus: Natural Progression of Diabetic Kidney Disease
by: Xiuqi Qiao, et al.
Published: (2025)

Kidney Effects of Finerenone Added to Sodium‐Glucose Cotransporter 2 Inhibitors in Patients With Diabetic Kidney Disease
by: Qing Yang, et al.
Published: (2026)

Global Burden of Cardiovascular Disease Attributable to Kidney Dysfunction and Trends, 1990–2021
by: Jiaorong Long, et al.
Published: (2025)

Efficacy and Safety of Jiedu Tongluo Therapy for Diabetic Kidney Disease Treatment: A Systematic Review and Meta‐Analysis
by: Yuxin Liu, et al.
Published: (2024)

Global Prevalence of Microvascular Complications in Children and Adolescents With Type 1 and Type 2 Diabetes: A Systematic Review and Meta‐Analysis
by: Yasmin Ezzatvar, et al.
Published: (2025)

Advancing Understanding of Epilepsy and Type 1 Diabetes Mellitus: A Global Perspective on Research Trends and Future Directions
by: Ruirui Zhang, et al.
Published: (2025)

Low Ankle‐Brachial Index Is Associated With Albuminuria and Diabetic Kidney Disease in Type 2 Diabetes; A Cross Sectional Study
by: Maryam Hedayati Moshkele, et al.
Published: (2025)

Association Between DNA Methylation of MTHFR and Diabetic Kidney Disease
by: Guoxiong Deng, et al.
Published: (2025)

Risk Stratification of Chronic Kidney Disease in Adults Using Noninvasive Fibrosis Tests Based on the American Diabetes Association Algorithm
by: Chan‐Young Jung, et al.
Published: (2026)

Tubular Injury in Diabetic Kidney Disease: Early Diagnosis and Intervention Strategies
by: Yi Lv, et al.
Published: (2025)

Global and regional estimates of hip fracture burden associated with type 1 diabetes from 1990 to 2021
by: Jing Li, et al.
Published: (2024)

Adding Finerenone to SGLT2 Inhibitors and Long‐Term Kidney Outcomes in Diabetic Kidney Disease
by: Masaru Matsui, et al.
Published: (2026)

Global, Regional, and National Temporal Trend and Patterns of Change in the Burden of Asthma From 1990 to 2021: An Analysis of the Global Burden of Disease Study 2021
by: Shuyi Mu, et al.
Published: (2025)

Huajuxiaoji Formula Alleviates Phenyl Sulfate‐Induced Diabetic Kidney Disease by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis
by: Zeng Zhang, et al.
Published: (2024)

Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum Metabolomics
by: Jiayuan He, et al.
Published: (2024)